Healthequity Stock Today

HQY -  USA Stock  

USD 62.80  1.82  2.98%

Market Performance
7 of 100
Odds Of Distress
Less than 6
Healthequity is trading at 62.80 as of the 28th of May 2022; that is 2.98 percent increase since the beginning of the trading day. The stock's open price was 60.98. Healthequity has only a 6 % chance of going through financial distress over the next few years but had a somewhat ok performance during the last 90 days. Equity ratings for Healthequity are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of November 2021 and ending today, the 28th of May 2022. Click here to learn more.
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company was incorporated in 2002 and is headquartered in Draper, Utah. Healthequity operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. The company has 83.6 M outstanding shares of which 4.14 M shares are currently shorted by investors with about 5.87 days to cover. More on Healthequity

Healthequity Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Healthequity's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Healthequity or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Healthequity has very high historical volatility over the last 90 days
The company reported the last year's revenue of 756.56 M. Reported Net Loss for the year was (44.29 M) with profit before taxes, overhead, and interest of 423.71 M.
Latest headline from These 4 Measures Indicate That HealthEquity Is Using Debt Extensively - Simply Wall St
Healthequity Fama & French Business Services
Business Services
Fama & French Classification
Healthequity SEC Filings
Healthequity SEC Filings Security & Exchange Commission EDGAR Reports
CEO and President and DirectorJon Kessler  (View All)
Average Analyst Recommendation
Analysts covering Healthequity report their recommendations after researching Healthequity's financial statements, talking to executives and customers, or listening in on Healthequity's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Healthequity. The Healthequity consensus assessment is calculated by taking the average forecast from all of the analysts covering Healthequity.
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Healthequity based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Healthequity financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 6 - HealthyDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares72.9 M83.1 M
Fairly Down
Slightly volatile
Weighted Average Shares Diluted76.5 M83.1 M
Significantly Down
Slightly volatile
Net Cash Flow from Operations117 M141 M
Significantly Down
Slightly volatile
Total Assets3.4 B3.1 B
Significantly Up
Slightly volatile
Total Liabilities1.4 B1.3 B
Significantly Up
Slightly volatile
Current Assets316.7 M351.3 M
Moderately Down
Slightly volatile
Current Liabilities165.3 M153.2 M
Significantly Up
Slightly volatile
Total DebtBB
Fairly Up
Slightly volatile
Return on Average Assets(0.0144)(0.014)
Fairly Down
Slightly volatile
Gross Margin0.630.56
Moderately Up
Slightly volatile
Asset Turnover0.250.242
Sufficiently Up
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Healthequity's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong BuyUndervalued
Financial Strength
Healthequity's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Healthequity's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Healthequity's financial leverage. It provides some insight into what part of Healthequity's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Healthequity's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Healthequity deploys its capital and how much of that capital is borrowed.
Healthequity cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 1.01 B in debt with debt to equity (D/E) ratio of 0.54, which is OK given its current industry classification. Healthequity has a current ratio of 2.24, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Healthequity until it has trouble settling it off, either with new capital or with free cash flow. So, Healthequity's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Healthequity sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Healthequity to invest in growth at high rates of return. When we think about Healthequity's use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

117.03 MillionShare
Healthequity (HQY) is traded on NASDAQ Exchange in USA. It is located in 15 West Scenic Pointe Drive and employs 3,688 people. Healthequity is listed under Business Services category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with total capitalization of 4.95 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Healthequity's market, we take the total number of its shares issued and multiply it by Healthequity's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Healthequity runs under Healthcare sector within Health Information Services industry. The entity has 83.6 M outstanding shares of which 4.14 M shares are currently shorted by investors with about 5.87 days to cover. Healthequity has about 225.41 M in cash with 141 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.69.
Check Healthequity Probability Of Bankruptcy
Healthequity secures a total of 83.6 Million outstanding shares. The majority of Healthequity outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Healthequity to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Healthequity. Please pay attention to any change in the institutional holdings of Healthequity as this could imply that something significant has changed or about to change at the company. Also note that almost three million three hundred fourty-four thousand invesors are currently shorting Healthequity expressing very little confidence in its future performance.

Ownership Allocation (%)

Check Healthequity Ownership Details

Healthequity Stock Price Odds Analysis

What are Healthequity's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Healthequity jumping above the current price in 90 days from now is about 55.35%. The Healthequity probability density function shows the probability of Healthequity stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the stock has a beta coefficient of 1.329. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Healthequity will likely underperform. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Healthequity is significantly underperforming DOW.
  Odds Below 62.8HorizonTargetOdds Above 62.8
44.55%90 days
Based on a normal probability distribution, the odds of Healthequity to move above the current price in 90 days from now is about 55.35 (This Healthequity probability density function shows the probability of Healthequity Stock to fall within a particular range of prices over 90 days) .

Healthequity Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Healthequity that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Healthequity's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Healthequity's value.
InstituionSecurity TypeTotal SharesValue
Blackrock IncCommon Shares9.4 M635.5 M
Vanguard Group IncCommon SharesM539.4 M
View Healthequity Diagnostics

Healthequity Historical Income Statement

Healthequity Income Statement is one of the three primary financial statements used for reporting Healthequity's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Healthequity revenue and expense. Healthequity Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Healthequity Direct Expenses is fairly stable at the moment as compared to the past year. Healthequity reported Direct Expenses of 286.41 Million in 2021. Cost of Revenue is likely to rise to about 359.1 M in 2022, whereas Consolidated Income is likely to drop (45.5 M) in 2022. View More Fundamentals

Healthequity Stock Against Markets

Picking the right benchmark for Healthequity stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Healthequity stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Healthequity is critical whether you are bullish or bearish towards Healthequity at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Healthequity without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Bond Directory Now


Bond Directory

Find actively traded corporate debentures issued by US companies
All  Next Launch Module

Healthequity Corporate Directors

Healthequity corporate directors refer to members of a Healthequity board of directors. The board of directors generally takes responsibility for the Healthequity's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Healthequity's board members must vote for the resolution. The Healthequity board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Evelyn Dilsaver - Independent DirectorProfile
Adrian Dillon - DirectorProfile
Debra McCowan - DirectorProfile
Frank Corvino - Independent DirectorProfile

Investing Healthequity

You need to understand the risk of investing before taking a position in Healthequity. The danger of trading Healthequity is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Healthequity is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Healthequity. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Healthequity is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please check Risk vs Return Analysis. Note that the Healthequity information on this page should be used as a complementary analysis to other Healthequity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for Healthequity Stock analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.